Application of Nanomaterial-Mediated Ferroptosis Regulation in Kidney Disease
Jiamin Zhu,1,* Zhen Zhang,1,2,* Yanhui Chu,1,* Zhongyin Xie,1 Dongmei Zeng,1 Lijiao Jin,1 Luxin Li1 1Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Mudanjiang Medical University, Mudanjiang, People’s Republic of China; 2School of First Clinical Medical College, Muda...
Saved in:
Main Authors: | Zhu J, Zhang Z, Chu Y, Xie Z, Zeng D, Jin L, Li L |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2025-02-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/application-of-nanomaterial-mediated-ferroptosis-regulation-in-kidney--peer-reviewed-fulltext-article-IJN |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metal‐based nanomaterials and nanocomposites as promising frontier in cancer chemotherapy
by: Sunil Kumar, et al.
Published: (2023-04-01) -
Iron and ferroptosis in kidney disease: molecular and metabolic mechanisms
by: Wenjie Wang, et al.
Published: (2025-02-01) -
Classification of Nanomaterial Drug Delivery Systems for Inflammatory Bowel Disease
by: Wang H, et al.
Published: (2025-02-01) -
Quercetin improves diabetic kidney disease by inhibiting ferroptosis and regulating the Nrf2 in streptozotocin-induced diabetic rats
by: Lei Zhang, et al.
Published: (2024-12-01) -
GLP‐1 Receptor Agonists Alleviate Diabetic Kidney Injury via β‐Klotho‐Mediated Ferroptosis Inhibition
by: Shasha Tian, et al.
Published: (2025-01-01)